162 related articles for article (PubMed ID: 19638620)
1. A prospective study of serum soluble CD30 concentration and risk of non-Hodgkin lymphoma.
Purdue MP; Lan Q; Martinez-Maza O; Oken MM; Hocking W; Huang WY; Baris D; Conde B; Rothman N
Blood; 2009 Sep; 114(13):2730-2. PubMed ID: 19638620
[TBL] [Abstract][Full Text] [Related]
2. Circulating sCD27 and sCD30 in pre-diagnostic samples collected fifteen years apart and future non-Hodgkin lymphoma risk.
Purdue MP; Lan Q; Hoffman-Bolton J; Hildesheim A; Callahan CL; Strickland P; Visvanathan K; Rothman N
Int J Cancer; 2019 Apr; 144(8):1780-1785. PubMed ID: 30230539
[TBL] [Abstract][Full Text] [Related]
3. Soluble levels of CD27 and CD30 are associated with risk of non-Hodgkin lymphoma in three Chinese prospective cohorts.
Bassig BA; Shu XO; Koh WP; Gao YT; Purdue MP; Butler LM; Adams-Haduch J; Xiang YB; Kemp TJ; Wang R; Pinto LA; Zheng T; Ji BT; Hosgood HD; Hu W; Yang G; Zhang H; Chow WH; Kim C; Seow WJ; Zheng W; Yuan JM; Lan Q; Rothman N
Int J Cancer; 2015 Dec; 137(11):2688-95. PubMed ID: 26095604
[TBL] [Abstract][Full Text] [Related]
4. Prediagnostic serum levels of cytokines and other immune markers and risk of non-hodgkin lymphoma.
Purdue MP; Lan Q; Bagni R; Hocking WG; Baris D; Reding DJ; Rothman N
Cancer Res; 2011 Jul; 71(14):4898-907. PubMed ID: 21632552
[TBL] [Abstract][Full Text] [Related]
5. Prediagnostic serum sCD27 and sCD30 in serial samples and risks of non-Hodgkin lymphoma subtypes.
Purdue MP; Lan Q; Langseth H; Grimsrud TK; Hildesheim A; Rothman N
Int J Cancer; 2020 Jun; 146(12):3312-3319. PubMed ID: 31523805
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum sCD23 and sCD30 up to two decades prior to diagnosis associated with increased risk of non-Hodgkin lymphoma.
Purdue MP; Lan Q; Kemp TJ; Hildesheim A; Weinstein SJ; Hofmann JN; Virtamo J; Albanes D; Pinto LA; Rothman N
Leukemia; 2015 Jun; 29(6):1429-31. PubMed ID: 25567136
[No Abstract] [Full Text] [Related]
7. Circulating soluble CD30 and future risk of lymphoma; evidence from two prospective studies in the general population.
Vermeulen R; Hosnijeh FS; Portengen L; Krogh V; Palli D; Panico S; Tumino R; Sacredote C; Purdue M; Lan Q; Rothman N; Vineis P
Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1925-7. PubMed ID: 21784955
[TBL] [Abstract][Full Text] [Related]
8. Soluble B-cell activation marker of sCD27 and sCD30 and future risk of B-cell lymphomas: A nested case-control study and meta-analyses.
Hosnijeh FS; Portengen L; Späth F; Bergdahl IA; Melin B; Mattiello A; Masala G; Sacerdote C; Naccarati A; Krogh V; Tumino R; Chadeau-Hyam M; Vineis P; Vermeulen R
Int J Cancer; 2016 May; 138(10):2357-67. PubMed ID: 26684261
[TBL] [Abstract][Full Text] [Related]
9. Elevated Serum Levels of sCD30 and IL6 and Detectable IL10 Precede Classical Hodgkin Lymphoma Diagnosis.
Levin LI; Breen EC; Birmann BM; Batista JL; Magpantay LI; Li Y; Ambinder RF; Mueller NE; Martínez-Maza O
Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1114-1123. PubMed ID: 28341757
[No Abstract] [Full Text] [Related]
10. Plasma Soluble CD30 as a Possible Marker of Adult T-cell Leukemia in HTLV-1 Carriers: a Nested Case-Control Study.
Takemoto S; Iwanaga M; Sagara Y; Watanabe T
Asian Pac J Cancer Prev; 2015; 16(18):8253-8. PubMed ID: 26745069
[TBL] [Abstract][Full Text] [Related]
11. Soluble cytokine receptor CD30 in atopic disorders: a case-control study.
Latza U; Davis S; Wilhelm D; McKnight B; Seyfarth M; Stein H
Clin Exp Allergy; 1999 Jan; 29(1):97-104. PubMed ID: 10051708
[TBL] [Abstract][Full Text] [Related]
12. B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS.
Grulich AE; Wan X; Law MG; Milliken ST; Lewis CR; Garsia RJ; Gold J; Finlayson RJ; Cooper DA; Kaldor JM
AIDS; 2000 Jan; 14(2):133-40. PubMed ID: 10708283
[TBL] [Abstract][Full Text] [Related]
13. Can serum soluble CD23 or CD30 predict the occurrence of lymphoma in HIV-infected patients?
Jarrin I; Boval B; Mazeron MC; Simoneau G; Magnier JD; Green A; Andreoli A; Bergmann JF; Sellier P
J Acquir Immune Defic Syndr; 2011 Jul; 57(3):e58-61. PubMed ID: 21860351
[No Abstract] [Full Text] [Related]
14. High serum level of soluble CD30 in acute primary HIV-1 infection.
Pizzolo G; Vinante F; Nadali G; Krampera M; Morosato L; Chilosi M; Raiteri R; Sinicco A
Clin Exp Immunol; 1997 May; 108(2):251-3. PubMed ID: 9158093
[TBL] [Abstract][Full Text] [Related]
15. A prospective analysis of circulating saturated and monounsaturated fatty acids and risk of non-Hodgkin lymphoma.
Chiu YH; Bertrand KA; Zhang S; Laden F; Epstein MM; Rosner BA; Chiuve S; Campos H; Giovannucci EL; Chavarro JE; Birmann BM
Int J Cancer; 2018 Oct; 143(8):1914-1922. PubMed ID: 29756258
[TBL] [Abstract][Full Text] [Related]
16. A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers.
Lim U; Freedman DM; Hollis BW; Horst RL; Purdue MP; Chatterjee N; Weinstein SJ; Morton LM; Schatzkin A; Virtamo J; Linet MS; Hartge P; Albanes D
Int J Cancer; 2009 Feb; 124(4):979-86. PubMed ID: 19035445
[TBL] [Abstract][Full Text] [Related]
17. Markers of microbial translocation and risk of AIDS-related lymphoma.
Marks MA; Rabkin CS; Engels EA; Busch E; Kopp W; Rager H; Goedert JJ; Chaturvedi AK
AIDS; 2013 Jan; 27(3):469-74. PubMed ID: 23169327
[TBL] [Abstract][Full Text] [Related]
18. Serologic markers of viral infection and risk of non-Hodgkin lymphoma: A pooled study of three prospective cohorts in China and Singapore.
Bassig BA; Willhauck-Fleckenstein M; Shu XO; Koh WP; Gao YT; Purdue MP; Xiang YB; Adams-Haduch J; Wang R; Brenner N; Waterboer T; Michel A; Ji BT; Hosgood HD; Rabkin CS; Yang G; Wong JYY; Zhang J; Hu W; Seow WJ; Chow WH; Pawlita M; Zheng W; Yuan JM; Lan Q; Rothman N
Int J Cancer; 2018 Aug; 143(3):570-579. PubMed ID: 29574937
[TBL] [Abstract][Full Text] [Related]
19. Associations between serum carotenoid levels and the risk of non-Hodgkin lymphoma: a case-control study.
Li S; Zhu X; Zhu L; Hu X; Wen S
Br J Nutr; 2020 Dec; 124(12):1311-1319. PubMed ID: 32349798
[TBL] [Abstract][Full Text] [Related]
20. A nested case-control study of non-Hodgkin lymphoma and serum organochlorine residues.
Rothman N; Cantor KP; Blair A; Bush D; Brock JW; Helzlsouer K; Zahm SH; Needham LL; Pearson GR; Hoover RN; Comstock GW; Strickland PT
Lancet; 1997 Jul; 350(9073):240-4. PubMed ID: 9242800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
